Ganirelix acetate inj Rx
Generic Name and Formulations:
Ganirelix acetate 250mcg per 0.5mL; soln for SC inj.
Merck & Co., Inc.
Indications for Ganirelix acetate inj:
Inhibition of premature LH surges in women undergoing controlled ovarian hyperstimulation.
After initiating FSH on day 2 or 3 of the cycle: 250mcg once daily SC during the mid to late follicular phase. Continue until the day of hCG.
Pregnancy (Cat.X). Nursing mothers.
Do complete gynecological and endocrinological exam first. Latex allergy.
Abdominal pain (gynecological), fetal death, headache, ovarian hyperstimulation syndrome, vaginal bleeding, injection site reactions, nausea, GI pain.
Prefilled syringe—1, 5, 50
Neurology Advisor Articles
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Patients With Multiple Sclerosis Face Greater Infection Risk
- Fingolimod Compared With Glatiramer Acetate in Head-to-Head MS Study
- Lower Relapse Risk and Disability Progression With Oral DMT in Treatment-Naive RRMS
- Anodal tDCS Offers Possible Benefit for Improving Item Recall in Post-Stroke Aphasia
- Hospitalization Tied to Brain Abnormalities in Older Adults
- Spending Often Persists in High-Cost Medicare-Medicaid Eligible
- Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
- High Frequency of Headaches Following Dialysis Associated With BUN and Blood Pressure